Exaggerated plasma fibrin formation (D-Dimer) in elderly alzheimer caregivers as compared to noncaregiving controls

Gerontology

Volumn 51, Issue 1, 2005, Pages 7-13

  Von Känel, Roland ^a,c   Dimsdale, Joel E ^a   Adler, Karen A ^a   Patterson, Thomas L ^a,b   Mills, Paul J ^a   Granta, Igor ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Alzheimer caregivers; Blood coagulation; Cardiovascular disease; Fibrinolysis; Psychological stress

Indexed keywords

ANTITHROMBIN III; BIOLOGICAL MARKER; D DIMER; FIBRIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD CLOTTING; BODY MASS; CARDIOVASCULAR RISK; CAREGIVER; CLINICAL ARTICLE; COMMUNITY CARE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FIBRIN FORMATION; FIBRINOLYSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MENTAL STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RISK; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SMOKING; UPREGULATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CAREGIVERS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; LONGITUDINAL STUDIES; MALE;

EID: 10644247463     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081428     Document Type: Article

References (44)

1. Schulz R, Beach SR: Caregiving as a risk factor for mortality: The Caregiver Health Effects Study. JAMA 1999;282:2215-2219.
2. Vitaliano PP, Scanlan JM, Zhang J, Savage MV, Hirsch IB, Siegler IC: A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosom Med 2002;64:418-435.
3. Shaw WS, Patterson TL, Ziegler MG, Dimsdale JE, Semple SJ, Grant I: Accelerated risk of hypertensive blood pressure recordings among Alzheimer caregivers. J Psychosom Res 1999;46:215-227.
4. Vitaliano PP, Russo J, Niaura R: Plasma lipids and their relationships with psychosocial factors in older adults. J Gerontol B Psychol Sci Soc Sci 1995;50:18-24.
5. Vitaliano PP, Scanlan JM, Krenz C, Fujimoto W: Insulin and glucose: Relationships with hassles, anger, and hostility in nondiabetic older adults. Psychosom Med 1996;58:489-499.
6. Schulz R, Newsom J, Mittelmark M, Burton L, Hirsch C, Jackson S: Health effects of caregiving: The caregiver health effects study: An ancillary study of the Cardiovascular Health Study. Ann Behav Med 1997;19:110-116.
7. Esterling BA, Kiecolt-Glaser JK, Bodnar JC, Glaser R: Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults. Health Psychol 1994;13:291-298.
8. Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong SY, Lubaroff DM: Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol A Biol Sci Med Sci 1999;54:M434-M439.
9. von Känel R, Dimsdale JE, Ziegler MG, Mills PJ, Patterson TL, Lee SK, Grant I: Effect of acute psychological stress on the hypercoagulable state in subjects (spousal caregivers of patients with Alzheimer's disease) with coronary or cerebrovascular disease and/or systemic hypertension. Am J Cardiol 2001;87:1405-1408.
10. von Känel R, Dimsdale JE, Patterson TL, Grant I: Association of negative life-event stress with coagulation activity in elderly Alzheimer caregivers. Psychosom Med 2003;65:145-150.
11. von Känel R, Dimsdale JE, Patterson TL, Grant I: Acute procoagulant stress response as a dynamic measure of allostatic load in Alzheimer caregivers. Ann Behav Med 2003;26:42-48.
12. Edwards RL, Rickles FR: The role of leukocytes in the activation of blood coagulation. Semin Hematol 1992;29:202-212.
13. McEver RP: Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001;86:746-756.
14. Lowe GD, Yarnell JW, Rumley A, Bainton D, Sweetnam PM: C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: Are inflammation and fibrin turnover linked in pathogenesis? Arterioscler Thromb Vasc Biol 2001;21:603-610.
15. Koenig W: Haemostatic risk factors for cardiovascular diseases. Eur Heart J 1998;19(suppl C):C39-C43.
16. Folsom AR: Hemostatic risk factors for atherothrombotic disease: An epidemiologic view. Thromb Haemost 2001;86:366-373.
17. Tracy RP: Hemostatic and inflammatory markers as risk factors for coronary disease in the elderly. Am J Geriatr Cardiol 2002;11:93-100, 107.
18. Pelzer H, Schwarz A, Heimburger N: Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988;59:101-106.
19. Lip GY, Lowe GD: Fibrin D-dimer: A useful clinical marker of thrombogenesis? Clin Sci 1995;89:205-214.
20. Lijnen HR, Collen D: Endothelium in hemostasis and thrombosis. Prog Cardiovasc Dis 1997;39:343-350.
21. Meyer D, Girma JP: von Willebrand factor: Structure and function. Thromb Haemost 1993;70:99-104.
22. Lip GY, Blann AD: von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J 1995;74:580-583.
23. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD: Fibrin D-dimer and coronary heart disease: Prospective study and meta-analysis. Circulation 2001;103:2323-2327.
24. Li YH, Teng JK, Tsai WC, Tsai LM, Lin LJ, Chen JH: Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction. J Am Coll Cardiol 1999;33:1543-1548.
25. Jansson JH, Nilsson TK, Johnson O: von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10-year follow up of survivors of acute myocardial infarction. Heart 1998;80:334-337.
26. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH: Endogenous tissue type plasminogen activator and risk of myocardial infarction. Lancet 1993;341:1165-1168.
27. Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Wiman B: Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 1987;ii:3-9.
28. von Känel R, Dimsdale JE: Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000;65:357-369.
29. von Känel R, Dimsdale JE, Adler KA, Dillon E, Perez C, Mills PJ: Effects of non-specific beta-adrenergic stimulation and blockade on blood coagulation in hypertension. J Appl Physiol 2003;94:1455-1459.
30. Oakley FR, Sanders TA, Miller GJ: Postprandial effects of an oleic acid-rich oil compared with butter on clotting factor VII and fibrinolysis in healthy men. Am J Clin Nutr 1998;68:1202-1207.
31. Ranby M, Nguyen G, Scarabin PY, Samama M: Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assay. Thromb Haemost 1989;61:409-414.
32. Kario K, Matsuo T, Kobayashi H, Yamamoto K, Shimada K: Earthquake-induced potentiation of acute risk factors in hypertensive elderly patients: Possible triggering of cardiovascular events after a major earthquake. J Am Coll Cardiol 1997;29:926-933.
33. von Känel R, Dimsdale JE: Fibrin D-dimer: A marker of psychosocial distress and its implications for research in stress-related coronary artery disease. Clin Cardiol 2003;26:164-168.
34. Shifman MA, Pizzo SV: The in vivo metabolism of antithrombin III and antithrombin III complexes. J Biol Chem 1982;257:3243-3248.
35. von Känel R, Mills PJ, Ziegler MG, Dimsdale JE: Effect of beta2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress. Am Heart J 2002;144:68-72.
36. Haley WE: The family caregiver's role in Alzheimer's disease. Neurology 1997;48(5 suppl 6):S25-S29.
37. Kiecolt-Glaser JK, Dura JR, Speicher CE, Trask OJ, Glaser R: Spousal caregivers of dementia victims: Longitudinal changes in immunity and health. Psychosom Med 1991;53:345-362.
38. von Känel R, Mills PJ, Fainman C, Dimsdale JE: Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: A biobehavioral pathway to coronary artery disease? Psychosom Med 2001;63:531-544.
39. Vrijkotte TG, van Doornen LJ, de Geus EJ: Work stress and metabolic and hemostatic risk factors. Psychosom Med 1999;61:796-805.
40. Ishizaki M, Tsuritani I, Noborisaka Y, Yamada Y, Tabata M, Nakagawa H: Relationship between job stress and plasma fibrinolytic activity in male Japanese workers. Int Arch Occup Environ Health 1996;68:315-320.
41. Appels A: Mental precursors of myocardial infarction. Br J Psychiatry 1990;156:465-471.
42. Raikkonen K, Lassila R, Keltikangas-Jarvinen L, Hautanen A: Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscler Thromb Vasc Biol 1996;16:363-367.
43. Kop WJ, Hamulyak K, Pernot C, Appels A: Relationship of blood coagulation and fibrinolysis to vital exhaustion. Psychosom Med 1998;60:352-358.
44. von Känel R, Frey K, Fischer JE: Independent relation of vital exhaustion and inflammation to fibrinolysis in apparently healthy subjects. Scand Cardiovasc J 2004;38:28-32.